Menu

Filtros : "FCF-FBF" Removidos: "Indexado no: BDENF" "IFSC555" "ICB-BMF" " GRU025" "ARTES" "Hong-Kong" "Irã" Limpar

Filtros

Refine with date range

1 - 20 (5.362 records)

  • Artigo de periodico-carta/editorial

    Empowering voices: inspiring women in medicinal chemistry [Editorial] (2024)

    Blanco, Maria Jesus ; Bronson, Joanne J ; DiMauro, Erin F ; Dzierba, Carolyn ; Eggen, MariJean ; Garner, Amanda L ; Georg, Gunda ; Giarolla, Jeanine ; Goodwin, Nicole C ; Davies, Melissa C. Grenier ; Luevano, Carrie Haskell ; Holzgrabe, Ulrike ; Huang, Rong ; Lagiakos, H. Rachel ; Leftheris, Katerina ; Martin, Yvonne; Matos, Maria João ; Dracka, Tricia L. May

    Source: Journal of Medicinal Chemistry. Unidade: FCF

    Subjects: MULHERES, QUÍMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BLANCO, Maria Jesus et al. Empowering voices: inspiring women in medicinal chemistry [Editorial]. Journal of Medicinal Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.1021/acsmedchemlett.4c00097. Acesso em: 07 set. 2024. , 2024

    • APA

      Blanco, M. J., Bronson, J. J., DiMauro, E. F., Dzierba, C., Eggen, M. J., Garner, A. L., et al. (2024). Empowering voices: inspiring women in medicinal chemistry [Editorial]. Journal of Medicinal Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1021/acsmedchemlett.4c00097

    • NLM

      Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen MJ, Garner AL, Georg G, Giarolla J, Goodwin NC, Davies MCG, Luevano CH, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, Dracka TLM. Empowering voices: inspiring women in medicinal chemistry [Editorial] [Internet]. Journal of Medicinal Chemistry. 2024 ; 67 4251-4258.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1021/acsmedchemlett.4c00097

    • Vancouver

      Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen MJ, Garner AL, Georg G, Giarolla J, Goodwin NC, Davies MCG, Luevano CH, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, Dracka TLM. Empowering voices: inspiring women in medicinal chemistry [Editorial] [Internet]. Journal of Medicinal Chemistry. 2024 ; 67 4251-4258.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1021/acsmedchemlett.4c00097

  • Artigo de periodico

    Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes (2024)

    Herrerias, Bruna Viggiano; Fernandes, Renan Caprucho; Gonzaga, Rodrigo Vieira ; Balista, Priscila Alves; Dario, Michelli Ferrera ; Sobreira, Flavia

    Source: Archives of Health. Unidade: FCF

    Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS, AGENTES ANTIMICROBIANOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HERRERIAS, Bruna Viggiano et al. Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes. Archives of Health, v. 5, n. 1, p. 17-26, 2024Tradução . . Disponível em: https://dx.doi.org/10.46919/archv5n1-003. Acesso em: 07 set. 2024.

    • APA

      Herrerias, B. V., Fernandes, R. C., Gonzaga, R. V., Balista, P. A., Dario, M. F., & Sobreira, F. (2024). Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes. Archives of Health, 5( 1), 17-26. doi:10.46919/archv5n1-003

    • NLM

      Herrerias BV, Fernandes RC, Gonzaga RV, Balista PA, Dario MF, Sobreira F. Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes [Internet]. Archives of Health. 2024 ; 5( 1): 17-26.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.46919/archv5n1-003

    • Vancouver

      Herrerias BV, Fernandes RC, Gonzaga RV, Balista PA, Dario MF, Sobreira F. Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes [Internet]. Archives of Health. 2024 ; 5( 1): 17-26.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.46919/archv5n1-003

  • Artigo de periodico

    Potential use of bixin beyond function as a natural colourant in food and cosmetics (2024)

    Takamoto, Rafael Teruiti de Oliveira; Hübner, Alexandra Almeida; Matuo, Míriam Cristina Sakuragui; Kikuchi, Irene Satiko

    Source: Natural Product Research. Unidade: FCF

    Subjects: CAROTENOIDES, URUCUM

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TAKAMOTO, Rafael Teruiti de Oliveira et al. Potential use of bixin beyond function as a natural colourant in food and cosmetics. Natural Product Research, 2024Tradução . . Disponível em: https://dx.doi.org/10.1080/14786419.2024.2350634. Acesso em: 07 set. 2024.

    • APA

      Takamoto, R. T. de O., Hübner, A. A., Matuo, M. C. S., & Kikuchi, I. S. (2024). Potential use of bixin beyond function as a natural colourant in food and cosmetics. Natural Product Research. doi:10.1080/14786419.2024.2350634

    • NLM

      Takamoto RT de O, Hübner AA, Matuo MCS, Kikuchi IS. Potential use of bixin beyond function as a natural colourant in food and cosmetics [Internet]. Natural Product Research. 2024 ;[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1080/14786419.2024.2350634

    • Vancouver

      Takamoto RT de O, Hübner AA, Matuo MCS, Kikuchi IS. Potential use of bixin beyond function as a natural colourant in food and cosmetics [Internet]. Natural Product Research. 2024 ;[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1080/14786419.2024.2350634

  • Artigo de periodico

    Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews (2024)

    Visacri, Marilia Berlofa ; Ribeiro, Mayra Carvalho; Komoda, Denis Satoshi; Duarte, Bruno Kosa Lino; Corrêa, Carlos Roberto Silveira; Maia, Flávia de Oliveira Motta ; Alves, Daniela Fernanda dos Santos

    Source: Value in Health Regional Issues. Unidade: FCF

    Subjects: MIELOMA MÚLTIPLO, REVISÃO SISTEMÁTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      VISACRI, Marilia Berlofa et al. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews. Value in Health Regional Issues, v. 43, p. 1-10 art. 100998, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.vhri.2024.100998. Acesso em: 07 set. 2024.

    • APA

      Visacri, M. B., Ribeiro, M. C., Komoda, D. S., Duarte, B. K. L., Corrêa, C. R. S., Maia, F. de O. M., & Alves, D. F. dos S. (2024). Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews. Value in Health Regional Issues, 43, 1-10 art. 100998. doi:10.1016/j.vhri.2024.100998

    • NLM

      Visacri MB, Ribeiro MC, Komoda DS, Duarte BKL, Corrêa CRS, Maia F de OM, Alves DF dos S. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews [Internet]. Value in Health Regional Issues. 2024 ; 43 1-10 art. 100998.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1016/j.vhri.2024.100998

    • Vancouver

      Visacri MB, Ribeiro MC, Komoda DS, Duarte BKL, Corrêa CRS, Maia F de OM, Alves DF dos S. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews [Internet]. Value in Health Regional Issues. 2024 ; 43 1-10 art. 100998.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1016/j.vhri.2024.100998

  • Artigo de periodico

    New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease (2024)

    Murta, Silvane Maria Fonseca ; Santana, Pedro Augusto Lemos ; Lapierre, thibault Joseph William Jacques Dit ; Penteado, André Berndt ; Hajje, Marissa El; Liarte, Daniel Barbosa; Souza, Mariana Laureano de ; Trossini, Gustavo Henrique Goulart ; Rezende Junior, Celso de Oliveira ; Oliveira, Renata Barbosa de; Ferreira, Rafaela S.

    Source: Expert Opinion on Drug Discovery. Unidade: FCF

    Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MURTA, Silvane Maria Fonseca et al. New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease. Expert Opinion on Drug Discovery, v. 19, n. 6, p. 741-753, 2024Tradução . . Disponível em: https://dx.doi.org/10.1080/17460441.2024.2349155. Acesso em: 07 set. 2024.

    • APA

      Murta, S. M. F., Santana, P. A. L., Lapierre, thibault J. W. J. D., Penteado, A. B., Hajje, M. E., Liarte, D. B., et al. (2024). New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease. Expert Opinion on Drug Discovery, 19( 6), 741-753. doi:10.1080/17460441.2024.2349155

    • NLM

      Murta SMF, Santana PAL, Lapierre thibault JWJD, Penteado AB, Hajje ME, Liarte DB, Souza ML de, Trossini GHG, Rezende Junior C de O, Oliveira RB de, Ferreira RS. New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease [Internet]. Expert Opinion on Drug Discovery. 2024 ; 19( 6): 741-753.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1080/17460441.2024.2349155

    • Vancouver

      Murta SMF, Santana PAL, Lapierre thibault JWJD, Penteado AB, Hajje ME, Liarte DB, Souza ML de, Trossini GHG, Rezende Junior C de O, Oliveira RB de, Ferreira RS. New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease [Internet]. Expert Opinion on Drug Discovery. 2024 ; 19( 6): 741-753.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1080/17460441.2024.2349155

  • Trabalho de evento-resumo

    Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus (2024)

    Contelli, Ana P; Ferraz, Gustavo C; Ferraz, Wítor R; Penteado, André Berndt ; Trossini, Gustavo Henrique Goulart ; Pedrozo, Eliane Correa

    Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química - RASBQ. Unidades: FCF, EEL

    Subjects: ENZIMAS, VENENOS DE ORIGEM ANIMAL

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CONTELLI, Ana P et al. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus. 2024, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2024. Disponível em: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos. Acesso em: 07 set. 2024.

    • APA

      Contelli, A. P., Ferraz, G. C., Ferraz, W. R., Penteado, A. B., Trossini, G. H. G., & Pedrozo, E. C. (2024). Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus. In Anais. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos

    • NLM

      Contelli AP, Ferraz GC, Ferraz WR, Penteado AB, Trossini GHG, Pedrozo EC. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus [Internet]. Anais. 2024 ;[citado 2024 set. 07 ] Available from: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos

    • Vancouver

      Contelli AP, Ferraz GC, Ferraz WR, Penteado AB, Trossini GHG, Pedrozo EC. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus [Internet]. Anais. 2024 ;[citado 2024 set. 07 ] Available from: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos

  • Artigo de periodico

    A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma (2024)

    Park, Ji Won; Pereira, Taynna Tatiane; Rotta, Inajara ; Lima, Tácio de Mendonça ; Aguiar, Patrícia Melo ; Visacri, Marilia Berlofa

    Source: International Journal of Clinical Pharmacy. Unidade: FCF

    Subjects: FARMACÊUTICOS, MIELOMA MÚLTIPLO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PARK, Ji Won et al. A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma. International Journal of Clinical Pharmacy, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s11096-024-01787-x. Acesso em: 07 set. 2024.

    • APA

      Park, J. W., Pereira, T. T., Rotta, I., Lima, T. de M., Aguiar, P. M., & Visacri, M. B. (2024). A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma. International Journal of Clinical Pharmacy. doi:10.1007/s11096-024-01787-x

    • NLM

      Park JW, Pereira TT, Rotta I, Lima T de M, Aguiar PM, Visacri MB. A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma [Internet]. International Journal of Clinical Pharmacy. 2024 ;[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1007/s11096-024-01787-x

    • Vancouver

      Park JW, Pereira TT, Rotta I, Lima T de M, Aguiar PM, Visacri MB. A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma [Internet]. International Journal of Clinical Pharmacy. 2024 ;[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1007/s11096-024-01787-x

  • Artigo de periodico

    Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system (2024)

    Vieira, Aline Rocha; Oliveira, Aline Furtado; Pessoa, Fabiana Vieira Lima Solino ; Miranda, Beatriz Nogueira Messias de; Baby, André Rolim

    Source: Scientia Pharmaceutica. Unidade: FCF

    Subjects: NANOPARTÍCULAS, GEOMETRIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      VIEIRA, Aline Rocha et al. Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system. Scientia Pharmaceutica, v. 92, p. 1-17 art. 43, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/scipharm92030043. Acesso em: 07 set. 2024.

    • APA

      Vieira, A. R., Oliveira, A. F., Pessoa, F. V. L. S., Miranda, B. N. M. de, & Baby, A. R. (2024). Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system. Scientia Pharmaceutica, 92, 1-17 art. 43. doi:10.3390/scipharm92030043

    • NLM

      Vieira AR, Oliveira AF, Pessoa FVLS, Miranda BNM de, Baby AR. Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system [Internet]. Scientia Pharmaceutica. 2024 ; 92 1-17 art. 43.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.3390/scipharm92030043

    • Vancouver

      Vieira AR, Oliveira AF, Pessoa FVLS, Miranda BNM de, Baby AR. Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system [Internet]. Scientia Pharmaceutica. 2024 ; 92 1-17 art. 43.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.3390/scipharm92030043

  • Artigo de periodico

    Dendrimers as drug delivery systems for oncotherapy: current status of promising applications (2024)

    Sueyoshi, Sophia Mikiko Oliveira; Silva, João Vitor da ; Guizze, Felipe; Giarolla, Jeanine

    Source: International Journal of Pharmaceutics. Unidade: FCF

    Subjects: MEDICAMENTO, NEOPLASIAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SUEYOSHI, Sophia Mikiko Oliveira et al. Dendrimers as drug delivery systems for oncotherapy: current status of promising applications. International Journal of Pharmaceutics, v. 663, p. 1-33 art. 124573, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.ijpharm.2024.124573. Acesso em: 07 set. 2024.

    • APA

      Sueyoshi, S. M. O., Silva, J. V. da, Guizze, F., & Giarolla, J. (2024). Dendrimers as drug delivery systems for oncotherapy: current status of promising applications. International Journal of Pharmaceutics, 663, 1-33 art. 124573. doi:10.1016/j.ijpharm.2024.124573

    • NLM

      Sueyoshi SMO, Silva JV da, Guizze F, Giarolla J. Dendrimers as drug delivery systems for oncotherapy: current status of promising applications [Internet]. International Journal of Pharmaceutics. 2024 ; 663 1-33 art. 124573.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1016/j.ijpharm.2024.124573

    • Vancouver

      Sueyoshi SMO, Silva JV da, Guizze F, Giarolla J. Dendrimers as drug delivery systems for oncotherapy: current status of promising applications [Internet]. International Journal of Pharmaceutics. 2024 ; 663 1-33 art. 124573.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1016/j.ijpharm.2024.124573

  • Artigo de periodico

    Controlled synthesis and structure characterization of a new fluconazole polymorph using analytical techniques and multivariate method (2024)

    Owoyemi, Bolaji Charles Dayo ; Silva, Cecília Carolina Pinheiro da ; Akinyemi, Amos Olalekan; Amuwaolorun, Banky Oluseye; Roque Flores, Roxana Lili; Araújo, Gabriel Lima Barros de ; Ellena, Javier ; Carneiro, Renato Lajarim

    Source: Scientific African. Unidades: IFSC, FCF

    Subjects: SOLUBILIDADE, ESPECTROSCOPIA RAMAN, POLIMORFISMO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      OWOYEMI, Bolaji Charles Dayo et al. Controlled synthesis and structure characterization of a new fluconazole polymorph using analytical techniques and multivariate method. Scientific African, v. 23, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.sciaf.2023.e02029. Acesso em: 07 set. 2024.

    • APA

      Owoyemi, B. C. D., Silva, C. C. P. da, Akinyemi, A. O., Amuwaolorun, B. O., Roque Flores, R. L., Araújo, G. L. B. de, et al. (2024). Controlled synthesis and structure characterization of a new fluconazole polymorph using analytical techniques and multivariate method. Scientific African, 23. doi:10.1016/j.sciaf.2023.e02029

    • NLM

      Owoyemi BCD, Silva CCP da, Akinyemi AO, Amuwaolorun BO, Roque Flores RL, Araújo GLB de, Ellena J, Carneiro RL. Controlled synthesis and structure characterization of a new fluconazole polymorph using analytical techniques and multivariate method [Internet]. Scientific African. 2024 ; 23[citado 2024 set. 07 ] Available from: https://doi.org/10.1016/j.sciaf.2023.e02029

    • Vancouver

      Owoyemi BCD, Silva CCP da, Akinyemi AO, Amuwaolorun BO, Roque Flores RL, Araújo GLB de, Ellena J, Carneiro RL. Controlled synthesis and structure characterization of a new fluconazole polymorph using analytical techniques and multivariate method [Internet]. Scientific African. 2024 ; 23[citado 2024 set. 07 ] Available from: https://doi.org/10.1016/j.sciaf.2023.e02029

  • Artigo de periodico

    Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment (2024)

    Passarin, Paula Beatriz Silva ; Lourenço, Felipe Rebello

    Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF

    Subjects: INDÚSTRIA FARMACÊUTICA, CROMATOGRAFIA LÍQUIDA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PASSARIN, Paula Beatriz Silva e LOURENÇO, Felipe Rebello. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, v. 239, p. 1-12, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2023.115907. Acesso em: 07 set. 2024.

    • APA

      Passarin, P. B. S., & Lourenço, F. R. (2024). Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, 239, 1-12. doi:10.1016/j.jpba.2023.115907

    • NLM

      Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907

    • Vancouver

      Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907

  • Artigo de periodico

    Enzymes for dermatological use (2024)

    Nascimento, Natália Santos do ; Obreque, Karin Mariana Torres ; Oliveira, Camila Areias de; Cunha, Jheniffer Rabelo ; Baby, André Rolim ; Long, Paul Frederick ; Young, Antony R ; Rangel-Yagui, Carlota de Oliveira

    Source: Experimental Dermatology. Unidade: FCF

    Subjects: ENZIMAS, DERMATOLOGIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      NASCIMENTO, Natália Santos do et al. Enzymes for dermatological use. Experimental Dermatology, v. 33, p. 1-20, 2024Tradução . . Disponível em: https://dx.doi.org/10.1111/exd.15008. Acesso em: 07 set. 2024.

    • APA

      Nascimento, N. S. do, Obreque, K. M. T., Oliveira, C. A. de, Cunha, J. R., Baby, A. R., Long, P. F., et al. (2024). Enzymes for dermatological use. Experimental Dermatology, 33, 1-20. doi:10.1111/exd.15008

    • NLM

      Nascimento NS do, Obreque KMT, Oliveira CA de, Cunha JR, Baby AR, Long PF, Young AR, Rangel-Yagui C de O. Enzymes for dermatological use [Internet]. Experimental Dermatology. 2024 ; 33 1-20.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1111/exd.15008

    • Vancouver

      Nascimento NS do, Obreque KMT, Oliveira CA de, Cunha JR, Baby AR, Long PF, Young AR, Rangel-Yagui C de O. Enzymes for dermatological use [Internet]. Experimental Dermatology. 2024 ; 33 1-20.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1111/exd.15008

  • Artigo de periodico

    The scenario of clays and clay minerals use in cosmetics/Dermocosmetics (2024)

    Sarruf, Fernanda Daud ; Contreras, Vecxi Judith Pereda; Martinez, Renata Miliani ; Velasco, Maria Valéria Robles ; Baby, André Rolim

    Source: Cosmetics. Unidade: FCF

    Subjects: ARGILAS, COSMÉTICOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SARRUF, Fernanda Daud et al. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics. Cosmetics, v. 11, p. 1-21, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/cosmetics11010007. Acesso em: 07 set. 2024.

    • APA

      Sarruf, F. D., Contreras, V. J. P., Martinez, R. M., Velasco, M. V. R., & Baby, A. R. (2024). The scenario of clays and clay minerals use in cosmetics/Dermocosmetics. Cosmetics, 11, 1-21. doi:10.3390/cosmetics11010007

    • NLM

      Sarruf FD, Contreras VJP, Martinez RM, Velasco MVR, Baby AR. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics [Internet]. Cosmetics. 2024 ; 11 1-21.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.3390/cosmetics11010007

    • Vancouver

      Sarruf FD, Contreras VJP, Martinez RM, Velasco MVR, Baby AR. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics [Internet]. Cosmetics. 2024 ; 11 1-21.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.3390/cosmetics11010007

  • Curadoria

    Reunião Anual da Sociedade Brasileira de Química- SBQ, 47 (2024)

    Cavalheiro, Carla Cristina Schmitt ; Lopes, Norberto Peporine ; Fornaro, Adalgiza ; Trossini, Gustavo Henrique Goulart

    Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química - RASBQ. Unidades: IQSC, FCFRP, IAG, FCF

    Subjects: QUÍMICA, CONGRESSO NACIONAL

    Versão PublicadaAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CAVALHEIRO, Carla Cristina Schmitt et al. Reunião Anual da Sociedade Brasileira de Química- SBQ, 47. Anais. São Paulo: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos. Acesso em: 07 set. 2024. , 2024

    • APA

      Cavalheiro, C. C. S., Lopes, N. P., Fornaro, A., & Trossini, G. H. G. (2024). Reunião Anual da Sociedade Brasileira de Química- SBQ, 47. Anais. São Paulo: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos

    • NLM

      Cavalheiro CCS, Lopes NP, Fornaro A, Trossini GHG. Reunião Anual da Sociedade Brasileira de Química- SBQ, 47 [Internet]. Anais. 2024 ;[citado 2024 set. 07 ] Available from: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos

    • Vancouver

      Cavalheiro CCS, Lopes NP, Fornaro A, Trossini GHG. Reunião Anual da Sociedade Brasileira de Química- SBQ, 47 [Internet]. Anais. 2024 ;[citado 2024 set. 07 ] Available from: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos

  • Artigo de periodico

    Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats (2024)

    Souza, Aline de ; Scarim, Cauê Benito ; Cotrim, Paulo César ; Barbosa Junior, Fernando ; Rocha, Bruno Alves ; Calixto, Leandro Augusto ; Correia, Cristiano de Jesus; Araujo, Gabriel Lima Barros de ; Löbenberg, Raimar ; Bou-Chacra, Nadia Araci ; Faloppa, Ana Cristina Breithaupt

    Source: Nanomedicine. Unidades: FM, FCFRP, FCF

    Subjects: LEISHMANIA, SISTEMA LINFÁTICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SOUZA, Aline de et al. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, v. 19, n. 4, p. 293-301, 2024Tradução . . Disponível em: https://dx.doi.org/10.2217/nnm-2023-0263. Acesso em: 07 set. 2024.

    • APA

      Souza, A. de, Scarim, C. B., Cotrim, P. C., Barbosa Junior, F., Rocha, B. A., Calixto, L. A., et al. (2024). Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, 19( 4), 293-301. doi:10.2217/nnm-2023-0263

    • NLM

      Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263

    • Vancouver

      Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263

  • Artigo de periodico

    Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs (2024)

    Almeida, Lígia Scandoglieri de; Chiavassa, Luísa Donatto ; Brito, Charles de Lima; Gatti, Fernando de Moura ; Trossini, Gustavo Henrique Goulart ; La Scalea, Mauro Aquiles

    Source: Journal of Applied Electrochemistry. Unidade: FCF

    Subjects: ELETROQUÍMICA, VOLTAMETRIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ALMEIDA, Lígia Scandoglieri de et al. Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs. Journal of Applied Electrochemistry, v. 54, p. 41-52, 2024Tradução . . Disponível em: https://doi.org/10.1007/s10800-023-01945-5. Acesso em: 07 set. 2024.

    • APA

      Almeida, L. S. de, Chiavassa, L. D., Brito, C. de L., Gatti, F. de M., Trossini, G. H. G., & La Scalea, M. A. (2024). Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs. Journal of Applied Electrochemistry, 54, 41-52. doi:10.1007/s10800-023-01945-5

    • NLM

      Almeida LS de, Chiavassa LD, Brito C de L, Gatti F de M, Trossini GHG, La Scalea MA. Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs [Internet]. Journal of Applied Electrochemistry. 2024 ; 54 41-52.[citado 2024 set. 07 ] Available from: https://doi.org/10.1007/s10800-023-01945-5

    • Vancouver

      Almeida LS de, Chiavassa LD, Brito C de L, Gatti F de M, Trossini GHG, La Scalea MA. Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs [Internet]. Journal of Applied Electrochemistry. 2024 ; 54 41-52.[citado 2024 set. 07 ] Available from: https://doi.org/10.1007/s10800-023-01945-5

  • Artigo de periodico

    Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation (2024)

    Bashir, Bushra; Alam, Shahbaz; Khandale, Nikhil; Birla, Devendra; Vishwas, Sukriti ; Pandey, Narendra Kumar; Gupta, Gaurav; Paudel, Keshav Raj ; Dureja, Harish; Kumar, Puneet; Singh, Thakur Gurjeet; Kuppusamy, Gowthamarajan; Zacconi, Flavia C; Pinto, Terezinha de Jesus Andreoli ; Dhanasekaran, Muralikrishnan; Gulati, Monica; Dua, Kamal ; Singh, Sachin Kumar

    Source: Ageing Research Reviews. Unidade: FCF

    Subjects: DOENÇAS NEURODEGENERATIVAS, ENVELHECIMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BASHIR, Bushra et al. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, v. 95, p. 1-16 art. 102236, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102236. Acesso em: 07 set. 2024.

    • APA

      Bashir, B., Alam, S., Khandale, N., Birla, D., Vishwas, S., Pandey, N. K., et al. (2024). Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, 95, 1-16 art. 102236. doi:10.1016/j.arr.2024.102236

    • NLM

      Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236

    • Vancouver

      Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236

  • Artigo de periodico

    In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors (2024)

    Yousef, Malaz ; O’Croinin, Conor; Le, Tyson S; Park, Chulhun ; Zuo, Jieyu; Bou-Chacra, Nadia Araci ; Davies, Neal M ; Löbenberg, Raimar

    Source: Pharmaceutics. Unidade: FCF

    Subjects: FARMACOCINÉTICA, FARMACODINÂMICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 07 set. 2024.

    • APA

      Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768

    • NLM

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768

    • Vancouver

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768

  • Artigo de periodico

    Recent advances in mitigating biofilms on medical devices (2024)

    Lirio, Adriana Cogo Malgueiro ; Ghisleni, Daniela Dal Molim ; Chellappan, Dinesh Kumar ; Dua, Kamal ; Pinto, Terezinha de Jesus Andreoli

    Source: ISAR Journal of Medical and Pharmaceutical Science. Unidade: FCF

    Subjects: BIOFILMES, VIRULÊNCIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LIRIO, Adriana Cogo Malgueiro et al. Recent advances in mitigating biofilms on medical devices. ISAR Journal of Medical and Pharmaceutical Science, v. 2, p. 19-22, 2024Tradução . . Disponível em: https://dx.doi.org/10.5281/zenodo.10876918. Acesso em: 07 set. 2024.

    • APA

      Lirio, A. C. M., Ghisleni, D. D. M., Chellappan, D. K., Dua, K., & Pinto, T. de J. A. (2024). Recent advances in mitigating biofilms on medical devices. ISAR Journal of Medical and Pharmaceutical Science, 2, 19-22. doi:10.5281/zenodo.10876918

    • NLM

      Lirio ACM, Ghisleni DDM, Chellappan DK, Dua K, Pinto T de JA. Recent advances in mitigating biofilms on medical devices [Internet]. ISAR Journal of Medical and Pharmaceutical Science. 2024 ; 2 19-22.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.5281/zenodo.10876918

    • Vancouver

      Lirio ACM, Ghisleni DDM, Chellappan DK, Dua K, Pinto T de JA. Recent advances in mitigating biofilms on medical devices [Internet]. ISAR Journal of Medical and Pharmaceutical Science. 2024 ; 2 19-22.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.5281/zenodo.10876918

  • Artigo de periodico

    Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin (2024)

    Richter, Luca Maurice ; Al-Gousous, Jozef ; Araujo, Gabriel Lima Barros de ; Davies, Neal M ; Löbenberg, Raimar

    Source: Journal of Drug Delivery Science and Technology. Unidade: FCF

    Subjects: DEPRESSÃO, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RICHTER, Luca Maurice et al. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, v. 92, p. 1-14, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jddst.2023.105305. Acesso em: 07 set. 2024.

    • APA

      Richter, L. M., Al-Gousous, J., Araujo, G. L. B. de, Davies, N. M., & Löbenberg, R. (2024). Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, 92, 1-14. doi:10.1016/j.jddst.2023.105305

    • NLM

      Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305

    • Vancouver

      Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 set. 07 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305

1 - 20 (5.362 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024